Provision Of Relenza Placebo Inhalers To Doctors, Pharmacists Planned
Glaxo plans to supply Relenza placebo diskhaler kits to doctors and pharmacists to facilitate training of patients in the proper administration of the influenza treatment if approved, the company said Feb. 24 at an advisory committee review of zanamivir.
You may also be interested in...
Glaxo plans to monitor patient experience with its Relenza Diskhaler through an "active" Phase IV program for the inhaled antiviral influenza treatment. FDA approved Relenza July 27.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011